Company / Accounts Receivable
NRC HEALTH Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$11.1M
FY2025
5-year range
$11.1M / $14.5M
FY2021-FY2025
Trend
+0.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable returned to growth in FY2025 after 2 years of decline, reaching $11M.
Based on SEC 10-K filings.
$11M in FY2025 with a 5-year CAGR of -4.4%.
Declined from $12M to $11M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -8.4%
- 5-Year CAGR
- -4.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -4.4%, indicating a declining trend.
- In FY2025, accounts receivable increased 0.5% year-over-year.
- Peak accounts receivable was recorded in FY2018.
- Lowest accounts receivable in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.1M | +0.5% |
| FY2024 | $11.1M | -10.7% |
| FY2023 | $12.4M | -14.4% |
| FY2022 | $14.5M | +5.3% |
| FY2021 | $13.7M | -1.4% |
| FY2020 | $13.9M | +19.6% |
| FY2019 | $11.6M | -20.7% |
| FY2018 | $14.7M | +10.0% |
| FY2017 | $13.3M | +22.8% |
| FY2016 | $10.9M | +10.8% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026